Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) ... Read More

Rapid Dose Announces Change of Auditor

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that it has changed its auditor from MNP LLP (“Former Auditor”) to SRCO Professional Corporation, Chartered Professional Accountants (“Successor Auditor”). At the request of the Company, the Former Auditor resigned as the auditor of the Company effective ... Read More